CBLL: CeriBell Corp Price Target Chart
CeriBell, Inc. (CBLL) develops mobile cloud EEG systems for emergency epilepsy detection, leveraging recognition from medical professionals. The brand implements energy-efficient electronics to reduce electronic waste, yet faces slow AI technology adoption by clinics and high promotional expenditures. The market trend on GURU.Markets, where the metric stands at 31.70, confirms the impact of these fundamental factors on the company's asset value.
Analytical breakdowns for CeriBell Corp (CBLL)
- market price and analyst price targets:
- market capitalization information:
- issuer book value statistics:
- issuer credit burden and liquidity indicators:
- financial results and valuation multiples details:
CBLL - Net Profit|Future Profit CeriBell, Inc.|CBLL - P/E Multiple|Projected Price to Earnings Ratio CeriBell Inc|CBLL - Price/Earnings to Growth Ratio|Business Value to Operating Income Before Depreciation CeriBell Corp|CBLL - Operating profit EBITDA|Net earnings per share for the last four quarters CeriBell|CBLL - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months ceribell.com|CBLL - Earnings growth in current year|Expected net earnings per share growth next year CeriBell, Inc.
Summary company analytics:CBLL ceribell.com
For CeriBell, Inc. (CBLL), the average projected price from investment banks reflects market expectations regarding the expansion of AI diagnostics in US intensive care units and subscription growth rates. This indicator synthesizes fragmented analyst estimates into a single retrospective curve, allowing investors to differentiate fundamental changes in business value from short-term speculative price fluctuations by comparing the current trend with historical data.
Competitors of CeriBell, Inc.
Consensus Target biogen.com BIIB|Analyst Consensus Forecast NBIX (Neurocrine Biosciences, Inc.)|Regencell Bioscience Ltd - Price Target Chart|AXSM - Price Target Chart|ACAD: Price Target Chart|Xenon Pharmaceuticals (XENE) - Price Target Chart|VKTX (vikingtherapeutics.com) - Price Target Chart|Price Target Chart Supernus|Broker Consensus Forecast CPRX (Catalyst Pharma)|Analyst Consensus Forecast DNLI|HRMY - Average Forecast Price|Biohaven Ltd. - Consensus Target|Analyst Consensus Forecast amylyx.com AMLX|TRVI - Price Target Chart|Fair Value Consensus PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Price Target Chart|Average Forecast Price Prothena Corporation plc (PRTA)|ALEC (Alector Inc.) - Analyst Consensus Forecast|Consensus Target annexonbio.com (ANNX)|Analyst Consensus Forecast OMER|NGNE - Average Forecast Price|Price Target Chart AC Immune Corp ACIU|Fair Value Consensus VYGR|Neumora Therapeutics - Analyst Consensus Forecast|Analyst Median Target scilexholding.com SCLX|TVGN: Analyst Consensus Forecast|ACOG (Alpha Cognition Inc.) - Price Target Chart|CGTX (Cognition Therapeutics) - Analyst Consensus Forecast|Average Forecast Price Inhibikase Pharma IKT|Price Target Chart Cassava Sciences, Inc. (SAVA)|Price Target Chart ASRT (assertiotx.com)|Price Target Chart Coya Therapeutics COYA|VistaGen Therapeutics, Inc. - Price Target Chart|OVID: Consensus Target|Fair Value Consensus ABOS (Acumen Pharmaceuticals, Inc)|CRVO: Analyst Consensus Forecast|ATHE - Analyst Median Target|Price Target Chart Clene Inc|Broker Consensus Forecast PEPG (PepGen Corp)|Analyst Consensus Forecast JUNS|Consensus Target Relmada Corp RLMD|Annovis Bio, Inc. - Consensus Target|Analyst Median Target Grace Therapeutics Inc (GRCE)|Firefly Neuroscience - Analyst Consensus Forecast|Klotho Neurosciences Inc (KLTO) - Consensus Target|NRSN: Analyst Consensus Forecast|RVPH (Reviva Pharmaceuticals, Inc.) - Price Target Chart|Price Target Chart MetaVia Inc.|Price Target Chart NRXS|Price Target Chart Helius Medical (HSDT)|Price Target Chart PASG (passagebio.com)|Price Target Chart Neuphoria Therapeutics NEUP|NERV: Broker Consensus Forecast|Athira Pharma, Inc. - Analyst Consensus Forecast|Average Forecast Price addextherapeutics.com|ALZN (alzamend.com) - Consensus Target|Cyclerion Therapeutics, Inc. (CYCN) - Analyst Consensus Forecast|Price Target Chart Protagenic Therapeutics Inc.|KTTA: Fair Value Consensus|Price Target Chart Cortigent, Inc. (CRGT)|ATXI - Average Forecast Price|Analyst Consensus Forecast BCLI (BrainStorm Cell Therapeutics)|CARA - Consensus Target|Chromocell Therapeutics Corporation - Analyst Consensus Forecast|Average Forecast Price Eliem Therapeutics|intracellulartherapies.com (ITCI) - Price Target Chart|longboardpharma.com - Fair Value Consensus|MRNS (Marinus Pharmaceuticals, Inc.) - Analyst Consensus Forecast|NKGen Biotech Inc (NKGN) - Analyst Median Target|Analyst Consensus Forecast NRBO|Price Target Chart SAGE (Sage Therapeutics Inc)|Analyst Consensus Forecast SNPX (Synaptogenix, Inc.)|trevena.com (TRVN) - Average Forecast Price|VIGL - Price Target Chart|WENA: Price Target Chart|Cerevel (CERE) - Price Target Chart
